least-square parameter estimation program rstrip (MicroMath Inc)
90
Structured Review
MicroMath Inc
least-square parameter estimation program rstrip
Least Square Parameter Estimation Program Rstrip, supplied by MicroMath Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/least-square+parameter+estimation+program+rstrip/least+square+parameter+estimation+program+rstrip/10__3109_slash_08982109409037063-98-17-21
Average 90 stars, based on 1 article reviews
Least Square Parameter Estimation Program Rstrip, supplied by MicroMath Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/least-square+parameter+estimation+program+rstrip/least+square+parameter+estimation+program+rstrip/10__3109_slash_08982109409037063-98-17-21
Average 90 stars, based on 1 article reviews
least-square parameter estimation program rstrip - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Clinical Proteomics:Article Title: Preclinical and Clinical Experience with Liposome-Encapsulated Mitoxantrone Article Snippet: Mitoxantrone (MTO) was encapsulared by different preparation techniques into lipsomes of different lipid compositions.. MTO complexed to liposomes containing phosphatiak acid (PA, PAMTO-lipsomes) had blood phannacokinetics which were comparable to the free h g . Accumulation in liver and spleen was signijicantly higher with PAMTO-liposomes.. Acute toxicity was 2.5 fold lower and the liposomal preparation had better antitumor effects in the L1210 leukemia and in a large cell lung cancer model. Drug discovery:Article Title: Preclinical and Clinical Experience with Liposome-Encapsulated Mitoxantrone Article Snippet: Mitoxantrone (MTO) was encapsulared by different preparation techniques into lipsomes of different lipid compositions.. MTO complexed to liposomes containing phosphatiak acid (PA, PAMTO-lipsomes) had blood phannacokinetics which were comparable to the free h g . Accumulation in liver and spleen was signijicantly higher with PAMTO-liposomes.. Acute toxicity was 2.5 fold lower and the liposomal preparation had better antitumor effects in the L1210 leukemia and in a large cell lung cancer model. Labeling:Article Title: Preclinical and Clinical Experience with Liposome-Encapsulated Mitoxantrone Article Snippet: Mitoxantrone (MTO) was encapsulared by different preparation techniques into lipsomes of different lipid compositions.. MTO complexed to liposomes containing phosphatiak acid (PA, PAMTO-lipsomes) had blood phannacokinetics which were comparable to the free h g . Accumulation in liver and spleen was signijicantly higher with PAMTO-liposomes.. Acute toxicity was 2.5 fold lower and the liposomal preparation had better antitumor effects in the L1210 leukemia and in a large cell lung cancer model. Modification:Article Title: Preclinical and Clinical Experience with Liposome-Encapsulated Mitoxantrone Article Snippet: Mitoxantrone (MTO) was encapsulared by different preparation techniques into lipsomes of different lipid compositions.. MTO complexed to liposomes containing phosphatiak acid (PA, PAMTO-lipsomes) had blood phannacokinetics which were comparable to the free h g . Accumulation in liver and spleen was signijicantly higher with PAMTO-liposomes.. Acute toxicity was 2.5 fold lower and the liposomal preparation had better antitumor effects in the L1210 leukemia and in a large cell lung cancer model. Liposomes:Article Title: Preclinical and Clinical Experience with Liposome-Encapsulated Mitoxantrone Article Snippet: Mitoxantrone (MTO) was encapsulared by different preparation techniques into lipsomes of different lipid compositions.. MTO complexed to liposomes containing phosphatiak acid (PA, PAMTO-lipsomes) had blood phannacokinetics which were comparable to the free h g . Accumulation in liver and spleen was signijicantly higher with PAMTO-liposomes.. Acute toxicity was 2.5 fold lower and the liposomal preparation had better antitumor effects in the L1210 leukemia and in a large cell lung cancer model. Injection:Article Title: Preclinical and Clinical Experience with Liposome-Encapsulated Mitoxantrone Article Snippet: Mitoxantrone (MTO) was encapsulared by different preparation techniques into lipsomes of different lipid compositions.. MTO complexed to liposomes containing phosphatiak acid (PA, PAMTO-lipsomes) had blood phannacokinetics which were comparable to the free h g . Accumulation in liver and spleen was signijicantly higher with PAMTO-liposomes.. Acute toxicity was 2.5 fold lower and the liposomal preparation had better antitumor effects in the L1210 leukemia and in a large cell lung cancer model. |